Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)
- N. Hatam
- , N. Ahmadloo
- , A. Ahmad Kia Daliri
- , P. Bastani
- , M. Askarian
Research output: Contribution to journal › Article › peer-review
23
Citations
(Scopus)